Histogenics Corp. | Mutual Funds
Mutual Funds that own Histogenics Corp.
Fidelity Select Biotechnology Portfolio
1,132,386
3.95%
0
0.04%
07/31/2018
Vanguard Total Stock Market Index Fund
630,548
2.2%
0
0%
07/31/2018
Fidelity Advisor Biotechnology Fund
504,068
1.76%
-93,166
0.05%
07/31/2018
Vanguard Extended Market Index Fund
232,341
0.81%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
100,000
0.35%
0
0.07%
12/31/2017
APO Medical Opportunities
82,618
0.28%
82,618
0.05%
03/31/2018
APO Medical Opportunities Institutionell
58,800
0.21%
0
0.09%
06/29/2018
Vanguard Institutional Total Stock Market Index Fund
51,282
0.18%
0
0%
07/31/2018
iShares Micro Cap ETF
48,836
0.17%
0
0.01%
09/06/2018
iShares Core S&P Total US Stock Market ETF
4,777
0.02%
0
0%
09/06/2018
| Address |
830 Winter Street
Waltham Massachusetts 02451
United States
|
|
Employees
|
- |
| Website |
http://www.histogenics.com |
| Updated |
07/08/2019 |
| Histogenics Corp. engages in the development, marketing, and commercialization of musculoskeletal medicine. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. |
